Balaxi Pharmaceuticals Limited Share Price and Company Fundamentals
Last traded: Today at 10:00 AM
Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceuticals, builders hardware, and FMCG products in Africa, the Caribbean Islands, and Latin America. The company offers pharmaceutical products across various therapeutic areas that mainly treats antibiotics, analgesic, anti-malaria, and others. It also provides biscuits and toothpastes. The company was formerly known as Balaxi Ventures Limited and changed its name to Balaxi Pharmaceuticals Limited in October 2020. Balaxi Pharmaceuticals Limited was incorporated in 1942 and is headquartered in Hyderabad, India. Balaxi Pharmaceuticals Limited is a subsidiary of Balaxi Overseas Private Limited.
Key Metrics
PE ratio
12.22
PB ratio
0.46
Dividend yield
-
Beta
0.59
Market cap
₹1.15B
Enterprise value
₹5.84B
Company profile
| Industry / Sector | Biotechnology / Healthcare |
|---|---|
| Website | https://balaxipharma.in |
| Mailing address | Maps Towers 3rd Floor Phase-III, Plot No.409, H.No. 8-2-293 Road No.81, Jubilee Hills Hyderabad 500096 India |
| Phone / Fax | 91 40 2355 5300 / 91 40 2355 8085 |
Dividends
Dividend yield
-
Dividend amount
₹-
Payout ratio
0.00%
5Y Avg. yield
-%
Balaxi Pharmaceuticals Limited paid ₹- dividend and the ex-dividend date was 01 Jul 2022.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.BALAXI dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Balaxi Pharmaceuticals Limited.
| Name | Title | Age | Total Pay |
|---|
Profitability and management effectiveness
Profit margin
-0.99%
Operating margin
21.39%
Return on assets
11.20%
Return on equity
-1.24%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Balaxi Pharmaceuticals Limited is 1.15B and its enterprise value is 5.84B. The enterprise value to revenue ratio of BALAXI is 2.42. The enterprise value to EBITDA ratio of BALAXI is 12.49.
The BALAXI's stocks Beta value is 0.59 making it 41% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Balaxi Pharmaceuticals Limited (NSE:BALAXI) Frequently Asked Questions
1. What is Balaxi Pharmaceuticals Limited's Stock Symbol?
Balaxi Pharmaceuticals Limited trades on NSE under the ticker symbol "BALAXI".
2. What is Balaxi Pharmaceuticals Limited's stock price today?
One share of BALAXI stock can currently be purchased for approximately ₹20.9.
3. How can I contact Balaxi Pharmaceuticals Limited?
Balaxi Pharmaceuticals Limited's mailing address is Maps Towers 3rd Floor Phase-III, Plot No.409, H.No. 8-2-293 Road No.81, Jubilee Hills Hyderabad 500096 India. The company can be reached via phone at 91 40 2355 5300.
4. What is Balaxi Pharmaceuticals Limited's official website?
The official website of Balaxi Pharmaceuticals Limited is https://balaxipharma.in.